COVID-19 series: The year of the vaccine

by DailyBriefers
0 comment


The year 2021 began with governments racing to obtain, and administer, COVID-19 shots produced by some of the pharmaceutical industry’s biggest names, as well as new rivals from China and Russia. At stake: The ability of countries to protect their people and revive dormant economies, with the wealthiest nations quickly taking the lead. All along the way, Reuters correspondents around the world have provided deeply reported insight and exclusive stories into the progress achieved by early leaders in vaccines; the industry’s setbacks in producing shots at unprecedented scale; the unequal access that has left many countries behind; and the new variants that are upending expectations of what will happen next in this pandemic.

Article Tags

Topics of Interest: Health

Type: The Big Picture

Sectors: Pharmaceuticals & Healthcare

Regions: Global

Win Types: ExclusivityOverall CoverageStorytelling

Story Types: Exclusive / ScoopHuman Interest / FeatureSpecial Report / Insight

Media Types: Multimedia

Customer Impact: Major Global Story

You may also like

Leave a Comment